实用老年医学 ›› 2023, Vol. 37 ›› Issue (10): 984-988.doi: 10.3969/j.issn.1003-9198.2023.10.003
张伟, 王蓉
收稿日期:2023-08-10
出版日期:2023-10-20
发布日期:2023-10-19
通讯作者:
王蓉,Email: rong_wang72@aliyun.com
作者简介:王蓉 教授
基金资助:
Received:2023-08-10
Online:2023-10-20
Published:2023-10-19
中图分类号:
张伟, 王蓉. 衰老作为神经退行性疾病危险因素的科学现状分析[J]. 实用老年医学, 2023, 37(10): 984-988.
| [1] KHALTOURINA D, MATVEYEV Y, ALEKSEEV A, et al. Aging fits the disease criteria of the international classification of diseases[J]. Mech Ageing Dev, 2020, 189:111230. [2] National Bureau of Statistics of China Bulletin of the Seventh National Census (No.5) [OL]. http://www.stats.gov.cn/ztjc/zdtjgz/zgrkpc/dqcrkpc/ggl/202105/t20210519_1817698.html. [3] BAI C, LEI X. New trends in population aging and challenges for China's sustainable development[J]. China Econ J, 2020, 13(1):3-23. [4] HOU Y, DAN X, BABBAR M, et al. Ageing as a risk factor for neurodegenerative disease[J]. Nat Rev Neurol, 2019, 15 (10):565-581. [5] WILSON D M, COOKSON M R, BOSCH L V D, et al. Hallmarks of neurodegenerative diseases[J]. Cell, 2023, 186 (4): 693-714. [6] LIU R M. Aging, cellular senescence, and Alzheimer's disease[J]. Int J Mol Sci, 2022, 23(4):1989. [7] BUSCHE M A, HYMAN B T. Synergy between amyloid-β and tau in Alzheimer's disease[J]. Nature Neuroscience, 2020, 23 (10):1183-1193. [8] ELOBEID A, LIBARD S, LEINO M, et al. Altered proteins in the aging brain[J]. J Neuropathol Exp Neurol, 2016, 75 (4):316-325. [9] TORRES D M C, CARDENAS F P. Synaptic plasticity in Alzheimer's disease and healthy aging[J]. Rev Neurosci, 2020, 31 (3):245-268. [10] RODRÍGUEZ-ARELLANO J J, PARPURA V, ZOREC R, et al. Astrocytes in physiological aging and Alzheimer's disease[J]. Neurosci, 2016, 323:170-182. [11] WILKINS H M, SWERDLOW R H. Mitochondrial links between brain aging and Alzheimer's disease[J]. Transl Neurodegener, 2021, 10 (1):33. [12] STERN Y.Cognitive reserve in ageing and Alzheimer's disease [J]. Neurology, 2012, 11 (11): 1006-1012. [13] SAEZ-ATIENZAR S, MASLIAH E. Cellular senescence and Alzheimer disease: the egg and the chicken scenario [J]. Neuroscience, 2020, 21 (8):433-444. [14] GUERRERO A, STROOPER B D, ARANCIBIA-CÁRCAMO I L. Cellular senescence at the crossroads of inflammation and Alzheimer's disease[J]. Trends Neurosci, 2021, 44 (9):714-727. [15] HOU Y, WEI Y, LAUTRUP S, et al. NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING[J]. Proc Natl Acad Sci U S A,2021, 118(37):e2011226118. [16] DORSEY E R, SHERER T, OKUN M S, et al. The emerging evidence of the Parkinson pandemic[J]. J Parkinson's Dis,2018, 8 (s1):S3-S8. [17] REEVE A, SIMCOX E, TURNBULL D, et al. Ageing and Parkinson's disease: why is advancing age the biggest risk factor? [J]. Ageing Res Rev, 2014, 14(100):19-30. [18] BOBELA W, AEBISCHER P, SCHNEIDER B L, et al. Αlpha-synuclein as a mediator in the interplay between aging and Parkinson's disease[J]. Biomolecules, 2015, 5 (4):2675-700. [19] ZUCCA F A, SEGURA-AGUILAR J, FERRARI E, et al. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease[J]. Prog Neurobiol, 2017, 155:96-119. [20] CALABRESE V, SANTORO A D, CRUPi R, et al. Aging and Parkinson's disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis[J]. Free Radic Biolo Med,2018, 115: 80-91. [21] SCHEIBLICH H, TROMBLY M, RAMIREZ A, et al. Neuroimmune connections in aging and neurodegenerative diseases[J]. Trends Immunol, 2020, 41 (4):300-312. [22] ZEIDAN R S, HAN S M, LEEUWENBURGH C, et al. Iron homeostasis and organismal aging[J]. Ageing Res Rev,2021, 72:101510. [23] JOHNSON A A, STOLZING A.The role of lipid metabolism in aging, lifespan regulation, and age-related disease[J]. Aging Cell, 2019, 18 (6):e13048. [24] OBERDOERFFER P, MICHAN S, MCVAY M, et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging[J]. Cell, 2008, 135 (5):907-918. [25] HAJJAR J E, CHATOO W, HANNA R, et al. Heterochromatic genome instability and neurodegeneration sharing similarities with Alzheimer's disease in old Bmi1+/-mice[J]. Sci Rep, 2019, 9 (1): 594. [26] BARZILAI A, SCHUMACHER B, SHILOH Y, et al. Genome instability: linking ageing and brain degeneration[J]. Mechan Ageing Dev, 2017, 161 (Pt A):4-18. [27] JEPPESEN D K, BOHR V A, STEVNSNER T, et al. DNA repair deficiency in neurodegeneration[J]. Prog Neurobiol,2011, 94 (2):166-200. [28] PAO P C, PATNAIK D, WATSON L A, et al. HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease[J]. Nat Commun, 2020, 11 (1): 2484. [29] SIAMETIS A, NIOTIS G, GARINIS G A, et al. DNA damage and the aging epigenome[J]. J Inv Dermatol, 2021, 141 (4S):961-967. [30] YOUSEFZADEH M, HENPITA C, VYAS R, et al. DNA damage-how and why we age? [J]. eLife, 2021, 10:e62852. [31] OU H L, SCHUMACHER B.DNA damage responses and p53 in the aging process[J]. Blood, 2018, 131 (5):488-495. [32] ZHAO Y, SIMON M, SELUANOV A, et al. DNA damage and repair in age-related inflammation[J]. Nat Rev Immunol, 2023, 23 (2):75-89. [33] LI X, CAO G, LIU, X, et al. Polymerases and DNA repair in neurons: implications in neuronal survival and neurodegenerative diseases[J]. Front Cell Neurosci, 2022, 16:852002. [34] CLARKE L E, LIDDELOW S A, CHAKRABORTY C, et al. Normal aging induces A1-like astrocyte reactivity[J]. Proc Natl Acad Sci U S A, 2018, 115 (8): E1896-E1905. [35] WANG J L, XU C J.Astrocytes autophagy in aging and neurodegenerative disorders [J]. Biomed Pharmacothera, 2020, 122:109691. [36] SILVIN A, UDERHARDT S, PIOT C, et al. Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration[J]. Immunity, 2022, 55 (8):1448-1465. [37] ROY E R, CHIU G, LI S, et al. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques[J]. Immunity, 2022, 55 (5): 879-894. [38] MARSCHALLINGER J, RAM T, ZARDENETA M, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain[J]. Nat Neurosci, 2020, 23 (2):194-208. [39] MCNAMARA N B, MUNRO D A D, Bestard-Cuche N, et al. Microglia regulate central nervous system myelin growth and integrity[J]. Nature, 2023, 613(7942):120-129. [40] AHN K, LEE S J, MOOK-JUNG I, et al. White matter-associated microglia: new players in brain aging and neurodegenerative diseases[J]. Ageing Res Rev, 2022, 75:101574. [41] PROPSON N E, ROY E R, LITVINCHUK A, et al. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging[J]. J Clin Invest, 2021, 131 (1):e140966. [42] XIAO X, XU M, YU H, et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src[J]. Signal Transduct Targeted Ther, 2021, 6 (1):354. [43] PANDIT R, CHEN L, GÖTZ J, et al. The blood-brain barrier: physiology and strategies for drug delivery[J]. Adv Drug Deliv Rev, 2020:165-166. [44] CHEN M B, YANG A C, YOUSEF H, et al. Brain endothelial cells are exquisite sensors of age-related circulatory cues[J]. Cell Rep, 2020, 30 (13):4418-4432. [45] ANDO S.Neuronal dysfunction with aging and its amelioration[J]. Proc Jpa AcadSer B Phys Biol Sci, 2012, 88 (6):266-282. [46] TURNER K J, VASU V, GRIFFIN D K, et al. Telomere biology and human phenotype[J]. Cells, 2019, 8 (1):73. [47] LÓPEZ-OTÍN C, BLASCO M A, PARTRIDGE L, et al. The hallmarks of aging[J]. Cell, 2013, 153 (6): 1194-1217. [48] GAO X, YU X, ZHANG C, et al. Telomeres and mitochondrial metabolism: implications for cellular senescence and age-related diseases[J]. Stem Cell Rev Rep, 2022, 18 (7):2315-2327. [49] PERKOVIC M N, PASKA A V, KONJEVOD M, et al. Epigenetics of Alzheimer's Disease[J]. Biomolecules, 2021, 11 (2):195. [50] MIWA S, KASHYAP S, CHINI E, et al. Mitochondrial dysfunction in cell senescence and aging[J]. J Clin Invest, 2022, 132 (13):e158447. [51] LIN M T, BEAL M F.Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases[J]. Nature, 2006, 443 (7113): 787-795. [52] LABBADIA J, MORIMOTO R I. The biology of proteostasis in aging and disease[J]. Annu Rev Biochem, 2015, 84:435-464. [53] MICÓ V, BERNINCHES L, TAPIA J, et al. Micromanaging nutrient sensing pathways through nutrition to promote healthy aging[J]. Inter J Mol Sci, 2017, 18 (5):195. [54] ESCOBAR K A, COLE N H, MERMIER C M, et al. Autophagy and aging: maintaining the proteome through exercise and caloric restriction[J]. Aging cell, 2019, 18 (1):e12876. [55] MADEO F, CARMONA-GUTIERREZ D, HOFER S J, et al. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential[J]. Cell Metab, 2019, 29(3): 592-610. [56] SAMERI S, SAMADI P, DEHGHAN R, et al. Stem cell aging in lifespan and disease: a state-of-the-art review[J]. Cur Stem Cell Res Ther, 2020, 15 (4):362-378. [57] ZHU Y, GE J, HUANG C. Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics[J]. Theranostics, 2021, 11 (12):5675-5685. [58] VANZULLI I, PAPANIKOLAOU M, DE-LA-ROCHA I C, et al. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer's disease[J]. Neurobiol Aging, 2020, 94: 130-139. [59] HUANG M, XU L, LIU J, et al. Cell-cell communication alterations via intercellular signaling pathways in substantia nigra of Parkinson's disease[J]. Front Aging Neurosci, 2022, 14: 828457. |
| [1] | 孙丽, 尹卫红, 经俊, 钱夏丽. 亚麻醉剂量艾司氯胺酮对老年脊柱手术病人术后早期认知功能障碍的影响[J]. 实用老年医学, 2024, 38(10): 1039-1043. |
| [2] | 董丽华, 李加梅, 郑加平, 雷小晶. 血液生物标志物在阿尔茨海默病早期诊断中的研究进展[J]. 实用老年医学, 2023, 37(12): 1249-1254. |
| [3] | 时建铨, 郑慧芬, 徐畅, 王变荣. 认知障碍简明评价量表与Addenbrooke认知评估量表Ⅲ诊断阿尔茨海默病的准确性比较[J]. 实用老年医学, 2023, 37(10): 1041-1043. |
| [4] | 阎子花, 杜静, 宋竹梅, 张兴梅, 张楠. 痴呆病人病感失认测评工具的研究进展[J]. 实用老年医学, 2023, 37(10): 1059-1063. |
| [5] | 王琳琳, 杨诗怡, 徐俊. 人工智能在阿尔茨海默病中的研究进展[J]. 实用老年医学, 2023, 37(9): 869-872. |
| [6] | 王敏, 郭文军, 汤忠泉, 赵晓敏, 欧婷, 李云涛. 听力障碍与阿尔茨海默病相关性的Meta分析[J]. 实用老年医学, 2023, 37(9): 915-919. |
| [7] | 段景宜, 刘静, 查玉航, 杨巧露, 何海洋, 马亚男, 高海英. 阿尔茨海默病医防融合模式的探索[J]. 实用老年医学, 2023, 37(8): 757-760. |
| [8] | 张绍敏, 吴锦晖. COVID-19与阿尔茨海默病的最新研究进展[J]. 实用老年医学, 2023, 37(5): 521-523. |
| [9] | 赵璨, 冯美江. 外泌体与阿尔茨海默病的研究进展[J]. 实用老年医学, 2023, 37(4): 335-338. |
| [10] | 朱贺, 殷实. 认知障碍与抑郁症关系的研究进展[J]. 实用老年医学, 2023, 37(3): 234-237. |
| [11] | 郭晓娟, 刘洁, 王瑾, 陆文惠, 高玲, 屈秋民. 西安地区阿尔茨海默病病人药物依从性调查及影响因素分析[J]. 实用老年医学, 2023, 37(1): 47-50. |
| [12] | 叶念思, 胡慧, 邓蓓, 刘雪婷, 周诗, 李雨灿, 王晓梦. 轻度认知障碍老年人口腔健康相关生活质量现状及影响因素分析[J]. 实用老年医学, 2024, 38(7): 674-678. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
|
